Intravitreal bevacizumab for treatment of choroidal neovascularization in pathologic myopia

Retina

Volumn 26, Issue 9, 2006, Pages 1093-1094

  Tewari, Asheesh ^b   Dhalla, Mandeep S ^b   Apte, Rajendra S ^a  

^a BARNES RETINA INSTITUTE   (United States)

^b NONE

Author keywords

Bevacizumab; Choroidal neovascularization; Intravitreal; Pathologic myopia

Indexed keywords

BENZOPORPHYRIN DERIVATIVE; BEVACIZUMAB;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; CASE REPORT; DRUG EFFICACY; EYE DISEASE; EYE EXAMINATION; FEMALE; FLUORESCENCE ANGIOGRAPHY; HUMAN; MYOPIA; OPTICAL COHERENCE TOMOGRAPHY; REPEATED DRUG DOSE; SINGLE DRUG DOSE; SUBRETINAL NEOVASCULARIZATION; TREATMENT OUTCOME; VISUAL ACUITY;

ADULT; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; CHOROIDAL NEOVASCULARIZATION; FEMALE; FLUORESCEIN ANGIOGRAPHY; HUMANS; INJECTIONS; MYOPIA, DEGENERATIVE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY; VITREOUS BODY;

EID: 33749627782     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.iae.0000254896.78766.74     Document Type: Article

References (6)

1. Michels S, Rosenfeld PJ, Puliafito CA, et al. Systemic bevacizumab (Avastin) therapy for neovascular age-related macular degeneration: twelve-week results of an uncontrolled openlabel clinical study. Ophthalmology 2005;112:1035-1047.
2. Rosenfeld PJ, Moshfeghi AA, Puliafito CA. Optical coherence tomography findings after an intravitreal injection of bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmic Surg Lasers Imaging 2005;36:331-335.
3. Blinder KJ, Blumenkranz MS, Bressler NM, et al. Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trial -VIP report no. 3. Ophthalmology 2003;110:667-673.
4. Krzystolik MG, Afshari MA, Adamis AP, et al. Prevention of experimental choroidal neovascularization with intravitreal anti-vascular endothelial growth factor antibody fragment. Arch Ophthalmol 2002;120:338-346.
5. Kabbinavar FF, Schulz J, McCleod M, et al. Addition of bevacizumab to bolus fluorouracil and leucovorin in first-line metastatic colorectal cancer: results of a randomized phase II trial. J Clin Oncol 2005;23:3697-3705.
6. Nguyen QD, Shah S, Tatlipinar S, et al. Bevacizumab suppresses choroidal neovascularization caused by pathological myopia. Br J Ophthalmol 2005;89:1368-1370.